Literature DB >> 22955014

Nitric oxide, can it be only good? Increasing the antioxidant properties of nitric oxide in hepatocytes by YC-1 compound.

Michal Aharoni-Simon1, Sarit Anavi, Uwe Beifuss, Zecharia Madar, Oren Tirosh.   

Abstract

The aim of the study was to evaluate the effect of Nitric oxide (NO) on redox changes and fat accumulation in hepatocytes. AML-12 hepatocytes were exposed to the NO donor Diethylenetriamine-NONOate (DETA-NO). DETA-NO led to a dose- and time-dependent increase in lipid accumulation in the cells, measured by Nile red fluorescence. Exposure of the cells to 1mM DETA-NO for 24h increased reactive oxygen species production, mainly peroxides. At the same time, NO induced elevation of reduced glutathione (GSH) and a mild activation of the antioxidant transcription factors Hypoxia-inducible factor 1α (HIF1α) and NF-E2 related factor 2 (Nrf-2). We used 100 μM YC-1 to inhibit HIF1α activity and induce activation of soluble Guanylate Cyclase (sGC). YC-1 alone did not affect fat accumulation, and only moderately increased the expression of Nrf-2-targeted genes Heme oxygenase 1 (Hmox1), NAD(P)H dehydrogenase (quinone 1) (Nqo1) and Glutathione S-transferase α1 (Gstα1). However, YC-1 abolished the negative effect of NO on fat accumulation when administered together. Strikingly, YC-1 potentiated the effect of NO on Nrf-2 activation, thus increasing dramatically the antioxidant properties of NO. Moreover, YC-1 intensified the effect of NO on the expression of peroxisome-proliferator-activated receptor-gamma co-activator 1α (PGC1α) and mitochondrial biogenesis markers. This study suggests that YC-1 may shift the deleterious effects of NO into the beneficial ones, and may improve the antioxidant properties of NO. 2012 Elsevier Inc. All rights reserved

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22955014     DOI: 10.1016/j.niox.2012.08.076

Source DB:  PubMed          Journal:  Nitric Oxide        ISSN: 1089-8603            Impact factor:   4.427


  3 in total

Review 1.  Hypoxic Signaling and Cholesterol Lipotoxicity in Fatty Liver Disease Progression.

Authors:  Oren Tirosh
Journal:  Oxid Med Cell Longev       Date:  2018-05-31       Impact factor: 6.543

2.  Amylin deposition activates HIF1α and 6-phosphofructo-2-kinase/fructose-2, 6-biphosphatase 3 (PFKFB3) signaling in failing hearts of non-human primates.

Authors:  Miao Liu; Nan Li; Chun Qu; Yilin Gao; Lijie Wu; Liangbiao George Hu
Journal:  Commun Biol       Date:  2021-02-12

3.  Acetaminophen cytotoxicity is ameliorated in a human liver organotypic co-culture model.

Authors:  Leonard J Nelson; Maria Navarro; Philipp Treskes; Kay Samuel; Olga Tura-Ceide; Steven D Morley; Peter C Hayes; John N Plevris
Journal:  Sci Rep       Date:  2015-12-03       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.